The funding will help the company progress the clinical development of mocravimod, a drug that could enhance the curative potential of an existing treatment for acute myeloid leukaemia.
The post Dublin’s Priothera raises €30m to develop leukaemia treatment appeared first on Silicon Republic.
https://bit.ly/3lGwGg3
https://bit.ly/3lGwGg3